Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC)
Clinical trial NCT05597761 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05597761
- Sponsor
- Oliver Cornely, MD
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-15
- Primary completion
- 2025-09-30
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.